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Abstract
Objective: To calculate a score of metabolic syndrome (MetS) in children and set a cutoff 
point of this score for the prediction of MetS risk. 
Methods: The study included a random sample of 348 children aged 8 and 9 years of Viço-
sa, Southeast Brazil. Factor analysis by principal components (PCA) was used to determi-
ne, among various risk factors, those with higher degrees of intercorrelation. The chosen 
variables were: waist circumference (PC), homeostatic model assessment of insulin re-
sistance (HOMA), high density lipoprotein (HDL), triglycerides (TAG) and mean arterial 
pressure (MAP). Z-scores were created for each one of these parameters and the sum of 
these z-scores constituted the MetS score. The receiver operating characteristic (ROC) 
curve was used to identify the cutoff of MetS score, using as gold standard the presence 
or absence of MetS determined according to criteria age-modified. 
Results: The prevalence of MetS in the sample was 8.9% by adopting specific criteria for 
age, and 24% when considering the cutoff of MetS score. The selected cutoff point of 1.86 
was accurate to predict the MetS risk in this sample due to its high sensitivity (96.7%), 
specificity (82.7%) and AUC of 0.96.
Conclusions: This original Brazilian study presents the MetS score as a suitable alterna-
tive for the study of Metabolic Syndrome in children, given the lack of consensus for the 
definition of this syndrome in childhood.
© 2015 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. All rights 
reserved.
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.11.001
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Risco de síndrome metabólica em crianças: a utilização de um escore único
Resumo
Objetivo: Calcular um escore de síndrome metabólica (SM) em crianças e definir um pon-
to de corte para a predição de risco de SM nesse grupo. 
Métodos: Estudo com amostra aleatória de 348 crianças de 8 e 9 anos do município de Vi-
çosa. Análise fatorial por componentes principais foi utilizada para verificar, entre vários 
fatores de risco, aqueles com maiores graus de intercorrelação, sendo estes: perímetro 
da cintura (PC), modelo homeostático de resistência à insulina (HOMA), lipoproteína de 
alta densidade (HDL), triacilgliceróis (TAG) e pressão arterial média (PAM). Escores-z fo-
ram criados para cada um desses parâmetros e o somatório destes constituiu o escore de 
SM. A curva receiver operating characteristic (ROC) foi utilizada para identificar o ponto 
de corte do escore, considerando-se como padrão-ouro a presença ou ausência de SM, 
segundo critérios modificados para a idade. 
Resultados: A prevalência de SM na amostra foi de 8,9% adotando-se critérios específicos 
para a idade, e de 24% quando considerado o ponto de corte do escore. Foi eleito o ponto 
de corte de 1,86, por possuir elevadas sensibilidade (96,7%) e especificidade (82,7%), 
AUC de 0,96, e assim, acurácia em predizer a presença de síndrome metabólica em 
crianças nessa faixa etária. 
Conclusões: Este inédito estudo brasileiro apresenta uma alternativa adequada para o 
estudo da SM em crianças, visto a ausência de definição consensual para a SM na infância.
© 2015 Sociedade de Pediatria de São Paulo. Publicado por Elsevier Editora Ltda. Todos os 
direitos reservados.
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Introduction
Metabolic syndrome (MetS) is a condition consisting of sev-
eral risk factors for cardiovascular disease and diabetes 
mellitus type 2.1 The etiology of MetS is not fully known, 
but probably represents a complex interaction between 
genetic, metabolic, environmental and dietary factors.2 Its 
clinical diagnosis, which has already been established for 
adults, is based on metabolic abnormalities that include 
abdominal obesity, dyslipidemia, high blood pressure (BP) 
and hyperglycemia.3
The extent of child obesity in Brazil can be demonstrated 
with data from the Pesquisa de Orçamentos Familiares 
(POF) carried out in the years 2008 and 2009, which showed 
that 33.5% of Brazilian children aged five to nine years had 
excess weight.4 Therefore, it is not surprising that some 
studies indicate the onset of MetS changes in childhood 
similar to those found in adults;5,6 however, there is no con-
sensus for the diagnosis of MetS in children.
Considering these facts, many authors have used a MetS 
score7-16 comprising a numerical representation of the com-
bination of metabolic and cardiovascular risk factors. 
However, to date, no studies have been found in Brazil that 
used this score. As it is a continuous variable, the MetS 
score is a measure that has greater statistical power when 
compared to the dichotomous classification of MetS (pres-
ence/absence).16,17 The use of the MetS score presupposes 
that the increased cardiovascular risk occurs due to the 
altogether progressive increase of the MetS parameters.18
Considering the increase in obesity and associated com-
plications in children, the lack of a consensus definition for 
MetS at this age range, and cardiovascular risk as a progres-
sive function of the several components of MetS, this study 
aimed to calculate a MetS score specific for the assessed 
children, using previously published methods,9,13 as well as 
define a cutoff indicating higher risk of MetS in the sample.
Method
This is a cross-sectional study of a random sample of chil-
dren aged 8 and 9 years, from public and private schools in 
urban and rural areas of the municipality of Viçosa, state 
of Minas Gerais, Brazil. This age group was chosen to inves-
tigate whether metabolic changes commonly observed in 
adolescence can already be observed, and possibly pre-
vented, in the final stage of childhood. Data collection 
occurred in the years 2012 and 2013.
Sample size was calculated based on the total number of 
students enrolled in the 3rd and 4th grades of all the local 
schools (n=1297). For the calculation, we considered a 50% 
prevalence of MetS, as there is no consensus regarding its 
diagnostic criteria. By using a prevalence of 50%, the max-
imum sample number is guaranteed. A permissible error of 
5% was considered, as well as a 95% confidence interval and 
sample loss of 20%, plus 10% for the multivariate analysis, 
resulting in an estimated sample of 385 children. The chil-
dren were organized into a specific worksheet in alphabet-
ical order and drawn using the “random” function in 
Microsoft Office Excel 2007 program. 
The study exclusion criteria were history of cardiovascu-
lar disease and type 1 diabetes and/or use of hypotensive 
or lipid-lowering medications, in addition to the existence 
of incomplete data.
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Blood samples were collected after a 12-hour fasting and 
analyzed in the Health Division clinical laboratory of 
Universidade Federal de Viçosa by trained professionals. 
High-density lipoprotein (HDL) and triacylglycerols (TAG) 
were measured by the enzymatic colorimetric method. The 
low-density lipoprotein (LDL) fraction was determined by 
the Friedewald, Fredrickson and Levy equation.19 Fasting 
glucose and insulin were measured by glucose oxidase and 
electrochemiluminescence method, respectively. The 
homeostatic model assessment (HOMA) was determined, 
which measures insulin resistance and consists in the product 
of fasting insulin (μUI/mL) and fasting glucose (mmol/L) 
divided by 22.5.20 Measures of adiposity assessed were body 
mass index (BMI) and waist circumference (WC). Based on 
measurements of weight (kg) and height (m), the Body Mass 
Index (BMI=body weight (kg)/height (m)2) was calculated. 
The WC was measured at the midpoint between the last rib 
and the iliac crest during a normal expiration, using a flexi-
ble, inelastic tape, with a length of 2 meters, divided into 
centimeters and subdivided into millimeters, being careful 
not to compress the soft parts.21 WC was measured in tripli-
cate and the final value was obtained by averaging the two 
closest measures.21,22 Systolic (SBP) and diastolic (DBP) blood 
pressure of the children was measured using a digital blood 
pressure device and cuff size appropriate for the age group.23 
For BP measurement, the child remained in the sitting posi-
tion for at least five minutes prior to the measurement.23 
The measurements were performed in both arms and the 
measure was repeated in the arm with the higher BP, which 
was the final measurement used.24 Before the measure-
ments, the child was asked about the need to urinate, pre-
vious practice of physical activity and the time elapsed since 
the last meal, considering the influence of these factors on 
BP.25 Mean blood pressure (MBP) was calculated, as it rep-
resents SBP and DBP in a single variable, by applying the 
following formula: MBP=[(SBP-DBP/3)+DBP].8,13
MetS was assessed using two methods: (1) classification 
according to pre-established criteria at the National 
Cholesterol Education Programme Adult Treatment Panel III 
(NCEP/ATP III) modified for age by de Ferranti et al.26 and 
(2) by the MetS score. The presence of MetS, as a categor-
ical variable, was verified by the alteration in at least three 
of the five criteria defined by the NCEP/ATP III, modified 
for age by de Ferranti et al.26 in a study using data from the 
Third National Health and Nutrition Examination Survey, 
1988-1994 (NHANES III), which considered the following 
cutoffs: HDL cholesterol <50 mg/dL; triacylglycerols ≥100 
mg/dL; fasting glucose ≥110 mg/dL; waist circumference 
>75th percentile for age and gender, and blood pressure 
≥90th percentile for age, gender and height. 
The variables that composed the MetS score were select-
ed according to the results of the Principal Component 
Analysis (PCA).27 The following variables were included in 
the PCA: BMI, WC, LDL, HDL, TAG, glucose, HOMA, SBP, DBP 
and MBP. Variables that had factor loadings >0.3 in retained 
components were selected to compose the MetS score,28 as 
follows: WC, TAG, HDL, HOMA and MBP. 
To calculate the MetS score, HDL was initially multiplied 
by –1, as high values  of this parameter are inversely related 
to metabolic risk.13 Z-scores of the WC, TAG, HDL, HOMA 
and MBP were calculated. The sum of these z-scores consti-
tuted a MetS score for each individual. Higher scores indi-
cate a less favorable metabolic profile.13
The MetS score cutoff for the study population was 
determined by the ROC curve, using as gold standard the 
presence of MetS according to the criteria adopted by de 
Ferranti et al.26 The cutoff that had maximum sensitivity 
and specificity was selected. We also analyzed the area 
under the ROC curve (AUC), which represents the capacity 
to use the MetS score to discriminate between those with 
and without MetS. The AUC was considered as the probabil-
ity that a child with MetS, selected at random, would have 
a higher MetS score than a child randomly chosen among 
individuals without MetS.13 The AUC was interpreted accord-
ing to the following guidelines: test due to chance 
(AUC=0.5); low accuracy (0.5<AUC≤0.7); moderate accura-
cy (0.7<AUC≤0.9); high accuracy (0.9<AUC<1.0), and per-
fect discriminatory test (AUC=1.0)29
Descriptive statistics were used to identify the number 
of individual risk factors for MetS (0, 1, 2, 3, or more). The 
sample characterization according to the MetS components 
assessed was performed for the total sample and stratified 
above or below the MetS score cutoff. The asymmetry of all 
variables was verified by the Shapiro-Wilk test. Differences 
between groups for continuous variables were verified by 
Mann-Whitney tests and by Pearson’s chi-square test for 
categorical variables. The chi-square partition with 
Bonferroni correction was used to compare the number of 
MetS components between genders. Statistical analysis was 
performed using the software SPSS 20.0 and Stata 9.1, with 
p<0.05 being considered significant. 
The present study was approved by the Ethics Committee 
in Human Research of Universidade Federal de Viçosa, pro-
cess No. 364 485/CEPH. Children’s participation was volun-
tary, after parents/guardians allowed them to participate 
and read and signed the free and informed consent form.
Results
Of the 365 participants assessed, 17 were excluded due to 
incomplete data, resulting in a sample of 348 children. The 
sample consisted of 59.2% of girls and 40.8% of boys; 48.9% 
were 8 years old and 51.1% were 9 years old.
As shown in Table 1, there was no significant difference 
between genders regarding the MetS score values. As for 
the frequency of the number of MetS components, only the 
occurrence of one MetS component in relation to the occur-
rence of no MetS component was higher among boys com-
pared to girls (p=0.001). The minimum and maximum MetS 
score values were -7.4 and 13.0, respectively. The presence 
of at least one MetS component was observed in 60.3% of 
the children. The prevalence of MetS found (≥3 compo-
nents) was 8.9%. No child had all the MetS components 
simultaneously.
The cutoff >75th percentile was used to classify the chil-
dren’s WC,26 and it corresponded to 66.05cm for girls and 
67.45cm for boys. The WC was altered in 24.7% of the sam-
ple.
The ROC curve analysis (Fig. 1) indicated high accuracy 
for the score to predict MetS, verified by the AUC of 0.96 
(95% CI: 0.94-0.99). The ROC curve also suggested different 
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Table 1 Score and number of components of metabolic syndrome in children aged 8 and 9 years. Viçosa, MG, 2012 and 2013.
Total sample Girls (n=206) Boys (n=142) p value
MetS score —0.58 (3.6) —0.80 (3.5) —0.29 (3.9) 0.220a
Components of MetS
0 138 (39.7) 94 (45.6) 44 (31.0) 0.013b
1 116 (33.3) 56 (27.2) 60 (42.2)
2  63 (18.1) 36 (17.5) 27 (19.0)
3 or more  31 (8.9) 20 (9.7) 11 (7.8)
MetS, metabolic syndrome.
MetS score shown as median (interquartile interval).
MetS Components shown as number of individuals (%).
a Mann-Whitney Test.
b Pearson’s chi-square.
Figure 1 Receiver operating characteristic (ROC) curve for 
the prediction of metabolic syndrome in children aged 8 and 
9 years using the metabolic syndrome score. AUC=0.96 
(95%CI: 0.94 to 0.99).
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MetS score cutoffs, and the cutoff point of 1.86 was cho-
sen, as it showed higher sensitivity (96.8%) and specificity 
(83.0%). Of the children, 24% (n=84) had MetS scores above 
the established cutoff (1.86), with this prevalence being 
much higher than that found according to the classification 
proposed by de Ferranti et al.26 (8.9%). It is noteworthy that 
higher scores indicate higher cardiovascular risk, with early 
risk detection being a fundamental aspect in the context of 
disease prevention. 
Table 2 shows that children with MetS score > cutoff 
(>1.86) had higher levels of all risk variables, with the 
exception of glucose, as well as higher percentage of alter-
ation of these variables and higher prevalence of MetS, 
according to the criteria of Ferranti et al.26 The most com-
mon abnormality was low HDL (44.0%), and the least com-
mon, hyperglycemia (0.6%).
Discussion
The prevalence of MetS among children in this study, 
according to the criteria adopted by de Ferranti et al.,26 
was 8.9%. In the study carried out by de Ferranti et al.26 in 
2004, with individuals aged 12-19 years participating in the 
NHANES III, a MetS prevalence of 9.2% was observed, simi-
lar to that found in the present study.
In 2003, Cook et al.5 had already analyzed the same sam-
ple studied by de Ferranti et al.,26 but with different cut-
offs for WC and lipid profile, and found a MetS prevalence 
of 4.2%. A study carried out in 2010 with children aged 7 to 
9 years found a MetS prevalence, according to the criteria 
defined by Cook et al.,5 of 5%, also lower than that identi-
fied in this study.13 It is noteworthy that there is no consen-
sual definition for MetS in children.
The use of the MetS score has been recommended by 
several authors as the most adequate alternative for epide-
miological analysis in the pediatric population.7,14,16 In the 
Corpus Christi Child Heart Study, which involved 403 chil-
dren, the variables selected to compose the MetS score, 
according to the factorial analysis, were: fasting insulin, 
TAG, HDL, SBP and BMI. In the aforementioned study, the 
MetS score was higher especially among Mexican-American 
boys compared to non-Hispanic Caucasian ones.7 In a study 
using data from individuals aged 12-17 years that partici-
pated in NHANES 1999-2002, the variables selected to com-
pose the MetS score according to the confirmatory factorial 
analysis were WC, TAG, SBP and fasting insulin. The authors 
showed the higher validity of the MetS score with the inclu-
sion of fasting insulin or HOMA index, compared to the 
validity when using fasting glucose to define MetS.11 A low 
association of glycemia with the other variables was also 
detected from the PCA in this study.
In this study, the AUC of 96.3%, observed in the ROC anal-
ysis, indicated the high accuracy of the MetS score to iden-
tify individuals with MetS, with the cutoff of 1.86 showing 
the highest sensitivity (96.7%) and specificity (82.7%). A sen-
sitivity value higher than the specificity has implications, 
such as the identification of individuals as having MetS when 
they do not actually have the syndrome. On the other hand, 
if a cutoff with a higher specificity than sensitivity had been 
chosen, the non-identification of several children with 
increased risk for MetS would occur. In this study, we chose 
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higher sensitivity, in comparison to specificity, aiming at 
using the MetS score for early identification of cardiometa-
bolic risk. Thus, children with MetS score above 1.86 should 
not be considered as having MetS, but being at greater risk 
for the development of MetS, when compared to those 
whose score is below the selected cutoff.
A study with children aged 7 to 9 years determined a 
cutoff of 3.72, for which optimal values of specificity 
(93.9%), sensitivity (100%) and AUC (0.98) were observed, 
demonstrating the applicability of using the MetS score in 
the study population, similar to what was demonstrated in 
the present study.13 Martínez-Vizcaíno et al.,14 in a study of 
1,020 Spanish children aged 10-13 years, confirmed the 
validity of the MetS score, which consisted of WC, MBP, 
TAG/HDL ratio and fasting insulin. The authors established 
a cutoff point of 4.2 from the ROC curve (sensitivity 94.1%, 
specificity 93.5%, AUC 0.98). In the two aforementioned 
studies,13,14 the NCEP/ATP III criteria was used as the gold 
standard for ROC analysis, modified for age by Cook et al.5 
The maintenance of the MetS score has been demon-
strated throughout life, emphasizing the preventive capac-
ity of the measure for predicting the risk at older ages.7,8 
The longitudinal Québec Family Study, which analyzed for 
12 years a sample of 147 individuals aged 8-18 years, 
demonstrated stability over time of both the individual risk 
indicators and the MetS score, which included the following 
variables: low HDL and elevated TAG, MBP, glycemia, sum 
of three trunk skinfolds and total cholesterol/HDL ratio.8
This study has limitations, such as the use of the score in 
clinical practice due to the complexity of data operational-
ization, being more applicable to epidemiological studies. 
Another limitation refers to the fact that the MetS score 
cutoff is specific for the assessed sample, which impairs 
the extrapolation of results to other populations. 
Reproduction of this approach by other authors will require 
the determination of a cut-off specific for the sample. 
Furthermore, the use of the MetS score resulted in a large 
increase in the prevalence of MetS in comparison to the 
dichotomous classification, which indicates the need of fur-
ther studies to assess the actual association of the score 
cutoff to higher cardiometabolic risk. It is worth mention-
ing that this study refers to the first phase of the investiga-
tion, which deals with the development of the score, that 
has good internal validity for schoolchildren aged 8-9 years. 
However, the external validity depends on a validation 
study of the score. Additionally, the study sample is repre-
sentative only of children aged 8 and 9 years from the 
municipality of Viçosa. It is recommended to carry out sim-
ilar studies with larger samples, considering their epidemi-
ological importance at national level, regarding the early 
detection of cardiovascular risk and prevention.
Despite the above limitations, this is the first Brazilian 
study that calculated a single MetS score, which represents 
the overall cardiometabolic risk of all components of the 
syndrome. By applying this method to a sample of children, 
we can overcome the limitations arising from the absence 
of a consensual definition for MetS in childhood, as well as 
the individual analysis of MetS components. By employing a 
score for each individual, it is assumed that those who have 
lower values disclose a better metabolic profile than those 
Table 2 Anthropometric, biochemical and clinical characteristics according to the presence or absence of metabolic syndrome 
according to a score in children aged 8 and 9 years. Viçosa, MG, 2012 and 2013.
Total sample MetS score (cutoff=1.86)
<1.86 ≥1.86
Cardiometabolic risk variables [median (interquartile interval)] p valuea
BMI (kg/m²) 16.5 (3.8) 15.8 (2.6) 21.0 (3.8) <0.001
WC (cm) 59.4 (11.0) 58.0 (7.3) 73.4 (11.4) <0.001
Glycemia (mg/dL) 88.0 (9.0) 88.0 (9.0) 89.0 (7.0) 0.092
HOMA 1.3 (1.0) 1.1 (0.8) 2.3 (1.4) <0.001
HDL (mg/dL) 52.0 (16.0) 54.0 (15.0) 45.0 (10.0) <0.001
TAG (mg/dL) 63.0 (39.0) 58.0 (30.0) 93.0 (58.5) <0.001
SBP (mm Hg) 98.0 (13.0) 96.0 (11.0) 107.5 (18.0) <0.001
DBP (mm Hg) 59.0 (11.5) 57.0 (9.5) 68.0 (11.0) <0.001
MetS component alteration, according to de Ferranti et al.26 [n (%)] p value
b
Elevated WC 86 (24.7) 22 (8.3) 64 (76.2) <0.001
Hyperglycemia 2 (0.6) 2 (0.8) 0 (0) 0.424
Low HDL 153 (44.0) 92 (34.9) 61 (72.6) <0.001
Elevated TAG 60 (17.2) 22 (8.3) 38 (45.2) <0.001
Elevated BP 38 (10.9) 14 (5.3) 24 (28.6) <0.001
Diagnosis of MetS, according to de Ferranti et al.26 [n (%)] p value
b
Absence of MetS 317 (91.1) 163 (99.6) 54 (64.3) <0.001
Presence of MetS 31 (8.9) 1 (0.4) 30 (35.7) <0.001
MetS, metabolic syndrome; BMI, body mass index; WC, waist circumference; HOMA, homeostatic model assessment of insulin resistance; 
HDL, high-density lipoprotein; TAG, triacylglycerols; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure; n, 
number of individuals.
a Mann-Whitney Test.
b Pearson’s chi-square test.
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with higher scores. The use of the MetS score is interesting, 
because being a numeric variable, it allows incorporating a 
higher level information to perform associative analysis, 
and by incorporating all risk factors in only one variable, it 
represents the overall cardiometabolic risk. 
It can be concluded that the PCA identified WC, HDL, TG, 
HOMA and MBP as the most appropriate and intercorrelated 
phenotypic characteristics to compose the MetS score in 
the sample. The HOMA index showed to be a more ade-
quate component than fasting glucose for the study of MetS 
in children, considering the results seen in the PCA and its 
clinical relevance in the physiopathology of the other MetS 
components. The results of this original Brazilian study 
have implications in epidemiological and clinical practice, 
as well as in public health, as the use of a single score for 
the study of MetS allows us to overcome the limitation of 
the lack of consensus regarding the definition of MetS in 
childhood and the age-specific cutoffs for each component. 
The cutoff selected for the score was able to identify a 
higher proportion of children (24%) exposed to increased 
cardiometabolic risk compared to the binary/dichotomous 
classification of MetS according to predefined criteria 
(8.9%). The MetS score, as a continuous variable, is a sta-
tistically more robust associative measure than the dichot-
omous syndrome classification, and is capable of represent-
ing the overall cardiometabolic risk of all components of 
MetS in a single variable.
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